Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Blood|July 15, 2016
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myelomaSyed Abbas Ali, Victoria Shi, Irina Maric, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete RemissionLuca Biavati, Carol Ann Huff, Anna Ferguson, et al.
Blood Advances|September 8, 2019
Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70Philip H Imus, Hua-Ling Tsai, Leo Luznik, et al.
Transplantation and Cellular Therapy|July 22, 2021
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System LymphomaCole H Sterling, Hua-Ling Tsai, Matthias Holdhoff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2020
Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation CyclophosphamideAmy E DeZern, Hany Elmariah, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease ProphylaxisPhilip H Imus, Hua-Ling Tsai, Amy E DeZern, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell TransplantationPhilip H Imus, Amanda L Blackford, Maria Bettinotti, et al.
Transplantation and Cellular Therapy|August 23, 2021
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation CyclophosphamideKatherine C Rappazzo, Marianna Zahurak, Maria Bettinotti, et al.
The Lancet. Haematology|March 18, 2019
Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trialJavier Bolaños-Meade, Kenneth R Cooke, Christopher J Gamper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple MyelomaJennifer N Brudno, Irina Maric, Steven D Hartman, et al.
Pageof 3